Tungstate decreases weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation

Endocrinology

Volumn 146, Issue 10, 2005, Pages 4362-4369

  Claret, Marc ^a   Corominola, Helena ^a   Canals, Ignasi ^a   Saura, Josep ^c   Barcelo Batllori, Silvia ^a   Guinovart, Joan J ^b   Gomis, Ramon ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INST D INVESTIGACIONS B   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TUNGSTEN DERIVATIVE; TUNGSTIC ACID; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CALORIC INTAKE; DYSLIPIDEMIA; ENERGY EXPENDITURE; GENE EXPRESSION; GROWTH RATE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ABSORPTION; LIPID OXIDATION; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; THERMOGENESIS; WEIGHT GAIN;

ADIPOSE TISSUE; ADMINISTRATION, ORAL; ANIMALS; ANTI-OBESITY AGENTS; BODY TEMPERATURE REGULATION; MALE; MEMBRANE MICRODOMAINS; OBESITY; RATS; RATS, WISTAR; TUNGSTEN COMPOUNDS; WEIGHT GAIN;

EID: 24944511514     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2005-0385     Document Type: Article

References (42)

1. Kopelman PG 2000 Obesity as a medical problem. Nature 404:635-643
2. Weigle DS 2003 Pharmacological therapy of obesity: past, present, and future J Clin Endocrinol Metab 88:2462-2469
3. Spiegelman BM, Flier JS 2001 Obesity and the regulation of energy balance. Cell 104:531-543
4. Bray GA, Tartaglia LA 2000 Medicinal strategies in the treatment of obesity. Nature 404:672-677
5. Giron MD, Caballero JJ, Vargas AM, Suarez MD, Guinovart JJ, Salto R 2003 Modulation of glucose transporters in rat diaphragm by sodium tungstate. FEBS Lett 542:84-88
6. Barbera A, Rodriguez-Gil JE, Guinovart JJ 1994 Insulin-like actions of tungstate in diabetic rats. Normalization of hepatic glucose metabolism. J Biol Chem 269:20047-20053
7. Munoz MC, Barbera A, Dominguez J, Fernandez-Alvarez J, Gomis R Guinovart JJ 2001 Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats. Diabetes 50:131-138
8. Barbera A, Fernandez-Alvarez J, Truc A, Gomis R, Guinovart JJ 1997 Effects of tungstate in neonatally streptozotocin-induced diabetic rats: mechanism leading to normalization of glycaemia. Diabetologia 40:143-149
9. Fernandez-Alvarez J, Barbera A, Nadal B, Barcelo-Batllori S, Piquer S, Claret M, Guinovart JJ, Gomis R 2004 Stable and functional regeneration of pancreatic β-cell population by tungstate treatment. Diabetologia 47:470-477
10. Prats E, Monfar M, Castella J, Iglesias R, Alemany M 1989 Energy intake of rats fed a cafeteria diet. Physiol Behav 45:263-272
11. Folch J, Lees M, Sloane GH 1957 A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509
12. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS 1995 Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311-1314
13. Desvergne B, Wahli W 1999 Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20:649-688
14. Evans RM, Barish GD, Wang YX 2004 PPARs and the complex journey to obesity. Nat Med 10:355-361
15. Dalgaard LT, Pedersen O 2001 Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and type II diabetes. Diabetologia 44:946-965
16. Brichard SM, Pottier AM, Henquin JC 1989 Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats. Endocrinology 125:2510-2516
17. Ozcelikay AT, Becker DJ, Ongemba LN, Pottier AM, Henquin JC, Brichard SM 1996 Improvement of glucose and lipid metabolism in diabetic rats treated with molybdate. Am J Physiol 270(2 Pt 1):E344-E352
18. McNeill JH, Delgatty HL, Battell ML 1991 Insulin-like effects of sodium selenate in streptozocin-induced diabetic rats. Diabetes 40:1675-1678
19. Domingo JL 2002 Vanadium and tungsten derivatives as antidiabetic agents: a review of their toxic effects. Biol Trace Elem Res 88:97-112
20. Le Lamer S, Cros G, Pinol C, Fernandez-Alvarez J, Bressolle F 2002 An application of population kinetics analysis to estimate pharmacokinetic parameters of sodium tungstate after multiple-dose during preclinical studies in rats. Pharmacol Toxicol 90:100-105
21. Le Lamer S, Cros G, Serrano JJ, Pinol C, Fernandez-Alvarez J, Bressolle F 2001 Estimation of pharmacokinetic parameters of sodium tungstate after multipledose during preclinical studies in beagle dogs. Eur J Pharm Sci 14:323-329
22. Le Lamer-Dechamps S, Poucheret P, Cros G, Bressolle F 2002 Influence of food and diabetes on pharmacokinetics of sodium tungstate in rat. Int J Pharm 248:131-139
23. Himms-Hagen J 1984 Thermogenesis in brown adipose tissue as an energy buffer. Implications for obesity. N Engl J Med 311:1549-1558
24. Saleh MC, Wheeler MB, Chan CB 2002 Uncoupling protein-2: evidence for its function as a metabolic regulator. Diabetologia 45:174-187
25. Schrauwen P, HesselinkM2002 UCP2 and UCP3 in muscle controlling body metabolism. J Exp Biol 205:2275-2285
26. Dulloo AG, Samec S, Seydoux J 2001 Uncoupling protein 3 and fatty acid metabolism. Biochem Soc Trans 29:785-791
27. Merkel M, Eckel RH, Goldberg IJ 2002 Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res 43:1997-2006
28. Storch J, Thumser AE 2000 The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta 1486:28-44
29. Kerner J, Hoppel C 2000 Fatty acid import into mitochondria. Biochim Biophys Acta 1486:1-17
30. Smith SJ, Cases S, Jensen DR, Chen HC, Sande E, Tow B, Sanan DA, Raber J, Eckel RH, Farese Jr RV 2000 Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet 25:87-90
31. Abu-Elheiga L, Oh W, Kordari P, Wakil, SJ 2003 Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc Natl Acad Sci USA 100:10207-10212
32. Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ 2000 Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291:2613-2616
33. Rossmeisl M, Syrovy I, Baumruk F, Flachs P, Janovska P, Kopecky J 2000 Decreased fatty acid synthesis due to uncoupling in adipose tissue. FASEB J 14:1793-1800
34. Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T 1998 Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 101:1354-1361
35. Oberfield JL, Collins JL, Holmes CP, Goreham DM, Cooper JP, Cobb JE, Lenhard JM, Hull-Ryde EA, Mohr CP, Blanchard SG, Parks DJ, Moore LB, Lehmann JM, Plunket K, Miller AB, Milburn MV, Kliewer SA, Willson TM 1996 A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation. Proc Natl Acad Sci USA 96:6102-6106
36. Rocchi S, Picard F, Vamecq J, Gelman L, Potier N, Zeyer D, Dubuquoy L, Bac P, Champy MF, Plunket KD, Leesnitzer LM, Blanchard SG, Desreumaux P, Moras D, Renaud JP, Auwerx J 2001 A unique PPARγ ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol Cell 8:737-747
37. Way JM, Harrington WW, Brown KK, Gottschalk WK, Sundseth SS, Mansfield TA, Ramachandran RK, Willson TM, Kliewer SA 2001 Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferatoractivated receptor γ activation has coordinate effects on gene expression in multiple insulin-sensitive tissues. Endocrinology 142:1269-1277
38. Berger JP, Petro AE, Macnaul KL, Kelly LJ, Zhang BB, Richards K, Elbrecht A, Johnson BA, Zhou G, Doebber TW, Biswas C, Parikh M, Sharma N, Tanen MR, Thompson GM, Ventre J, Adams AD, Mosley R, Surwit RS, Moller DE 2003 Distinct properties and advantages of a novel peroxisome proliferatoractivated protein (γ) selective modulator. Mol Endocrinol 17:662-676
39. Hu E, Kim JB, Sarraf P, Spiegelman BM 1996 Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274:2100-2103
40. Camp HS, Tafuri SR 1997 Regulation of peroxisome proliferator-activated receptor-γ activity by mitogen-activated protein kinase. J Biol Chem 272: 10811-10816
41. Zhang B, Berger J, Zhou G, Elbrecht A, Biswas S, White-Carrington S, Szalkowski D, Moller DE 1996 Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor γ. J Biol Chem 271:31771-31774
42. Dominguez JE, Munoz MC, Zafra D, Sanchez-Perez I, Baque S, Caron M, Mercurio C, Barbera A, Perona R, Gomis R, Guinovart JJ 2003 The antidiabetic agent sodium tungstate activates glycogen synthesis through an insulin receptor-independent pathway. J Biol Chem 278:42785-42794